Matches in Wikidata for { <http://www.wikidata.org/entity/Q62025591> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q62025591 description "clinical trial" @default.
- Q62025591 description "ensayu clínicu" @default.
- Q62025591 description "klinisch onderzoek" @default.
- Q62025591 description "клінічне випробування" @default.
- Q62025591 description "临床试验" @default.
- Q62025591 name "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Metastatic Solid Tumors or Lymphomas." @default.
- Q62025591 type Item @default.
- Q62025591 label "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Metastatic Solid Tumors or Lymphomas." @default.
- Q62025591 prefLabel "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Metastatic Solid Tumors or Lymphomas." @default.
- Q62025591 P1050 Q62025591-69DE01D2-97FC-4991-8C36-354C99B65B67 @default.
- Q62025591 P1132 Q62025591-CD04977D-A60A-410F-AAB1-D58D926E3285 @default.
- Q62025591 P1476 Q62025591-594F7054-F030-44EE-B477-EF1160C2D05F @default.
- Q62025591 P17 Q62025591-F9056988-EB10-434D-ADD1-89AFFABF4465 @default.
- Q62025591 P2899 Q62025591-A5DC9315-AA89-478A-8A30-97EDF308700F @default.
- Q62025591 P3098 Q62025591-BDAB222B-3201-4F13-A625-6E4966FE3578 @default.
- Q62025591 P31 Q62025591-EDD6B592-4571-48C5-A424-AC6A0E2BC294 @default.
- Q62025591 P580 Q62025591-DF6D4756-192C-410E-AA47-707EA34A9477 @default.
- Q62025591 P582 Q62025591-E6114D1F-C3B1-40F5-9FAF-A93A1A5F2467 @default.
- Q62025591 P6099 Q62025591-6AC7A7FC-AE9F-434D-BCA3-4328EFA24A22 @default.
- Q62025591 P6153 Q62025591-250693C8-3433-4795-B0F0-29F626406179 @default.
- Q62025591 P6153 Q62025591-5D286ACA-3D6F-48AC-94EF-4A589F74B040 @default.
- Q62025591 P6153 Q62025591-8A3CB0C4-4427-46D5-8571-6602FA75EB6C @default.
- Q62025591 P6153 Q62025591-8D66CC10-ECC3-426D-A4BC-60934A673DCB @default.
- Q62025591 P6153 Q62025591-E587C403-A1F2-402E-B73F-403E257F435D @default.
- Q62025591 P8005 Q62025591-EC974827-3A7B-4056-894E-AD4B1E53FFF8 @default.
- Q62025591 P8363 Q62025591-B6E59F0F-5FD3-47C4-BF01-CC4C3975BF8B @default.
- Q62025591 P1050 Q208414 @default.
- Q62025591 P1132 "+80" @default.
- Q62025591 P1476 "An Open Label, Dose-Escalation Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of TAK-981 in Adult Patients With Metastatic Solid Tumors or Lymphomas." @default.
- Q62025591 P17 Q30 @default.
- Q62025591 P2899 "+18" @default.
- Q62025591 P3098 "NCT03648372" @default.
- Q62025591 P31 Q30612 @default.
- Q62025591 P580 "2018-10-01T00:00:00Z" @default.
- Q62025591 P582 "2021-02-16T00:00:00Z" @default.
- Q62025591 P6099 Q5452194 @default.
- Q62025591 P6153 Q1047060 @default.
- Q62025591 P6153 Q126412 @default.
- Q62025591 P6153 Q4858714 @default.
- Q62025591 P6153 Q5476635 @default.
- Q62025591 P6153 Q7896459 @default.
- Q62025591 P8005 Q76649708 @default.
- Q62025591 P8363 Q78089383 @default.